Latest Biotech News

CytomX released expansion‑cohort results for its masked, conditionally activated antibody‑drug conjugate Varseta‑M in late‑line metastatic colorectal cancer, reporting response rates between 20%...

BioMarin announced it will stop dosing certain patients in two mid‑stage trials of Voxzogo following reports of slipped capital femoral epiphysis (SCFE) in independent studies. The company flagged...

ARPA‑H awarded BioCurie up to $9.3 million to develop an AI‑driven, scalable manufacturing platform for viral and non‑viral gene therapies. The program will integrate machine learning,...

Trenchant BioSystems struck an engineering and development collaboration with Invetech to advance its AutoCell platform toward commercialization, targeting fully automated, point‑of‑care cell and...

Illumina and Veritas Genetics have formed a preventive genomics consortium to bring whole‑genome sequencing into proactive healthcare, offering an opt‑in program that combines Illumina’s...

CirCode Biomed received FDA clearance to begin a U.S. clinical trial of its circular RNA therapeutic, marking a first test of the circular RNA modality in the American regulatory environment. The...

Shanghai‑based Unixell Biotech received FDA clearance to start a Phase 1 trial of UX‑GIP001, an iPSC‑derived, allogeneic cell therapy for focal epilepsy resistant to drugs. The first‑in‑human...

Roche announced an expanded partnership with Nvidia to bolster its AI 'factory' for drug and diagnostic development, aiming to accelerate model training, molecular design, and diagnostic pipelines...

Structure Therapeutics reported mid-stage results showing its oral GLP-1 candidate aleniglipron produced an average ~16% body-weight reduction at 44 weeks, a magnitude that approaches injectable...

A U.S. district judge issued a temporary block on major elements of Health Secretary Robert F. Kennedy Jr.'s overhaul of federal childhood vaccine policy, staying the CDC's decision to reduce...

CytomX Therapeutics released Phase 1 expansion data showing its masked antibody‑drug conjugate Varseta‑M achieved 20–32% response rates in heavily pretreated colorectal cancer cohorts and extended...

BioMarin announced a dosing pause for subsets of patients in two Phase 2 trials of Voxzogo after independent studies flagged hip‑related adverse events—specifically cases of slipped capital...

ARPA‑H awarded BioCurie up to $9.3 million to develop an AI‑powered digital platform aimed at accelerating and de‑risking gene therapy manufacturing. The grant funds computational modeling,...

Trenchant BioSystems and engineering partner Invetech announced a collaboration to finalize and commercialize the AutoCell platform, a fully automated cell‑and‑gene therapy (CGT) manufacturing...

Japan’s CRO CMIC partnered with Bluenote to deploy agentic AI across protocol development, statistical planning and study reports, aiming to accelerate regulatory documentation by up to 75% per...

Illumina and Veritas Genetics announced a consortium to integrate whole‑genome sequencing (WGS) into preventive healthcare, combining Illumina’s sequencing and DRAGEN analysis with Veritas’...

CirCode Biomed secured U.S. FDA clearance to begin a clinical trial testing its circular RNA therapeutic platform, marking a notable regulatory green light for an emerging genetic‑medicine...

Centers for Medicare & Medicaid Services granted coverage for NeoGenomics’ PanTracer LBx blood‑based comprehensive genomic profiling test for advanced solid tumors, potentially widening access to...

Structure Therapeutics reported Phase 2 efficacy and tolerability data for its oral GLP-1 candidate aleniglipron showing pronounced weight loss and improved retention. In a trial of 61 treated...

Illumina and Veritas Genetics announced a consortium to integrate whole-genome sequencing into preventive healthcare pathways across the U.S. and other markets. Illumina will bring sequencing,...